ZA200200094B - Nitrogen containing heterobicycles as factor xa inhibitors. - Google Patents
Nitrogen containing heterobicycles as factor xa inhibitors.Info
- Publication number
- ZA200200094B ZA200200094B ZA200200094A ZA200200094A ZA200200094B ZA 200200094 B ZA200200094 B ZA 200200094B ZA 200200094 A ZA200200094 A ZA 200200094A ZA 200200094 A ZA200200094 A ZA 200200094A ZA 200200094 B ZA200200094 B ZA 200200094B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitors
- nitrogen containing
- factor
- heterobicycles
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14434499P | 1999-07-16 | 1999-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200200094B true ZA200200094B (en) | 2003-04-30 |
Family
ID=22508178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200200094A ZA200200094B (en) | 1999-07-16 | 2002-01-04 | Nitrogen containing heterobicycles as factor xa inhibitors. |
Country Status (18)
Country | Link |
---|---|
US (2) | US6429205B1 (fr) |
EP (1) | EP1196412B1 (fr) |
JP (1) | JP2004507439A (fr) |
KR (1) | KR20030011268A (fr) |
CN (1) | CN1454211A (fr) |
AT (1) | ATE268766T1 (fr) |
AU (1) | AU2481501A (fr) |
BR (1) | BR0013200A (fr) |
CA (1) | CA2380727A1 (fr) |
DE (1) | DE60011430T2 (fr) |
ES (1) | ES2222257T3 (fr) |
HK (1) | HK1045502B (fr) |
IL (1) | IL147317A0 (fr) |
MX (1) | MXPA02000537A (fr) |
NO (1) | NO20020217L (fr) |
PL (1) | PL357108A1 (fr) |
WO (1) | WO2001005784A1 (fr) |
ZA (1) | ZA200200094B (fr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339099B1 (en) * | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
EP1192132B1 (fr) | 1999-06-14 | 2005-09-07 | Eli Lilly And Company | Composes |
AU2001234690A1 (en) | 2000-02-01 | 2001-08-14 | Cor Therapeutics, Inc. | 2-(1h)-quinolone and 2-(1h)-quinoxalone inhibitors of factor xa |
US20020013314A1 (en) * | 2000-02-01 | 2002-01-31 | Bing-Yan Zhu | 3,4-dihydro-2H-benzo[1,4]oxazine inhibitors of factor Xa |
AU2001256733A1 (en) * | 2000-05-16 | 2001-11-26 | Takeda Chemical Industries Ltd. | Melanin-concentrating hormone antagonist |
WO2002000655A1 (fr) | 2000-06-23 | 2002-01-03 | Bristol-Myers Squibb Pharma Company | Derives de pyrazole condenses par 1 - (heteroaryl-phenyl) utilises comme inhibiteurs du facteur xa |
WO2002000647A1 (fr) | 2000-06-23 | 2002-01-03 | Bristol-Myers Squibb Pharma Company | Inhibiteurs du facteur xa a substitution heteroaryl-phenyle |
ATE544750T1 (de) | 2001-09-21 | 2012-02-15 | Bristol Myers Squibb Co | Lactamhaltige verbindungen und ihre derivate als faktor-xa-hemmer |
TWI331526B (en) | 2001-09-21 | 2010-10-11 | Bristol Myers Squibb Pharma Co | Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
TW200302225A (en) | 2001-12-04 | 2003-08-01 | Bristol Myers Squibb Co | Substituted amino methyl factor Xa inhibitors |
AU2002350217A1 (en) | 2001-12-04 | 2003-06-17 | Bristol-Myers Squibb Company | Glycinamides as factor xa inhibitors |
BR0307178A (pt) * | 2002-01-22 | 2004-12-07 | Du Pont | Composto, composição e método para controle de pragas invertebradas |
CN1633296A (zh) | 2002-03-26 | 2005-06-29 | 贝林格尔·英格海姆药物公司 | 糖皮质素模拟物、其制备方法、药物组合物及其用途 |
AU2003273179A1 (en) | 2002-05-10 | 2003-12-12 | Bristol-Myers Squibb Company | 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
JP2006504678A (ja) * | 2002-08-21 | 2006-02-09 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用 |
EP2982668A3 (fr) | 2002-12-03 | 2016-04-13 | Pharmacyclics LLC | Dérivés de 2-(2-hydroxybiphényl-3-yl)-1h-benzoimidazole-5-carboxamidine en tant qu'inhibiteurs du facteur viia inhibitors pour le traitement de maladies thromboemboliques |
EP1581523B1 (fr) * | 2002-12-23 | 2009-09-30 | Sanofi-Aventis Deutschland GmbH | Derives du pyrazole en tant qu'inhibiteurs du facteur xa |
EP1479678A1 (fr) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Derivés du pyrazole en tant qu'inhibiteurs du facteur Xa |
US7429581B2 (en) | 2002-12-23 | 2008-09-30 | Sanofi-Aventis Deutschland Gmbh | Pyrazole-derivatives as factor Xa inhibitors |
US7122557B2 (en) | 2003-03-18 | 2006-10-17 | Bristol-Myers Squibb Company | Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors |
US7129264B2 (en) * | 2003-04-16 | 2006-10-31 | Bristol-Myers Squibb Company | Biarylmethyl indolines and indoles as antithromboembolic agents |
UY28526A1 (es) | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
US20050124664A1 (en) * | 2003-10-30 | 2005-06-09 | Eric Sartori | Urea thiadiazole inhibitors of plasminogen activator inhibior-1 |
US7795272B2 (en) | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
WO2006047415A2 (fr) * | 2004-10-26 | 2006-05-04 | Janssen Pharmaceutica, N.V. | Composes inhibiteurs du facteurs xa |
WO2006071609A2 (fr) | 2004-12-27 | 2006-07-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Composes mimetiques glucocorticoides, compositions pharmaceutiques les contenant, et methodes de fabrication et d'utilisation de ceux-ci |
GT200600042A (es) * | 2005-02-10 | 2006-09-27 | Aventis Pharma Inc | Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a |
DE102005038947A1 (de) * | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
AU2007329548A1 (en) | 2006-12-06 | 2008-06-12 | Boehringer Ingelheim International Gmbh | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
KR20100017766A (ko) * | 2007-05-10 | 2010-02-16 | 에이엠알 테크놀로지, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로벤조-1,4-디아제핀 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 이의 용도 |
CN102112476A (zh) | 2008-06-06 | 2011-06-29 | 贝林格尔.英格海姆国际有限公司 | 糖皮质激素模拟物、其制备方法、药物组合物及其用途 |
BR112014030147B1 (pt) * | 2012-06-22 | 2019-10-15 | Sumitomo Chemical Company, Limited | Compostos heterocíclicos fundidos, composição e método para controlar pestes |
JP7017524B2 (ja) * | 2016-05-23 | 2022-02-15 | ザ ロックフェラー ユニバーシティー | 自己免疫疾患を治療するためのアミノアシルインダゾール免疫調節薬 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001502655A (ja) | 1995-12-21 | 2001-02-27 | デュポン ファーマシューティカルズ カンパニー | Xa因子阻害薬であるイソオキサゾリン、イソチアゾリンおよびピラゾリン |
WO1998028269A1 (fr) * | 1996-12-23 | 1998-07-02 | Du Pont Pharmaceuticals Company | COMPOSES HETEROAROMATIQUES CONTENANT DE L'AZOTE, UTILISES EN TANT QU'INHIBITEURS DU FACTEUR Xa |
ATE236890T1 (de) | 1996-12-23 | 2003-04-15 | Bristol Myers Squibb Pharma Co | Sauerstoff oder schwefel enthaltende 5-gliedrige heteroaromatishe derivative als factor xa hemmer |
HUP0003906A2 (hu) | 1997-06-19 | 2001-05-28 | Du Pont Pharmaceuticals Co. | Xa faktort gátló hatású heterociklusos vegyületek és ezeket tartalmazó gyógyszerkészítmények |
ZA985247B (en) * | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
JP2001526268A (ja) | 1997-12-22 | 2001-12-18 | デュポン ファーマシューティカルズ カンパニー | Xa因子阻害剤としての、オルト−置換P1を有する、窒素含有複素環式芳香族化合物 |
-
2000
- 2000-07-12 BR BR0013200-4A patent/BR0013200A/pt not_active IP Right Cessation
- 2000-07-12 MX MXPA02000537A patent/MXPA02000537A/es unknown
- 2000-07-12 CN CN00819731A patent/CN1454211A/zh active Pending
- 2000-07-12 EP EP00982716A patent/EP1196412B1/fr not_active Expired - Lifetime
- 2000-07-12 DE DE60011430T patent/DE60011430T2/de not_active Expired - Lifetime
- 2000-07-12 JP JP2001511443A patent/JP2004507439A/ja active Pending
- 2000-07-12 PL PL00357108A patent/PL357108A1/xx not_active Application Discontinuation
- 2000-07-12 KR KR1020027000658A patent/KR20030011268A/ko not_active Application Discontinuation
- 2000-07-12 ES ES00982716T patent/ES2222257T3/es not_active Expired - Lifetime
- 2000-07-12 AU AU24815/01A patent/AU2481501A/en not_active Abandoned
- 2000-07-12 AT AT00982716T patent/ATE268766T1/de not_active IP Right Cessation
- 2000-07-12 IL IL14731700A patent/IL147317A0/xx unknown
- 2000-07-12 CA CA002380727A patent/CA2380727A1/fr not_active Abandoned
- 2000-07-12 WO PCT/US2000/018903 patent/WO2001005784A1/fr active IP Right Grant
- 2000-07-13 US US09/615,465 patent/US6429205B1/en not_active Expired - Lifetime
-
2002
- 2002-01-04 ZA ZA200200094A patent/ZA200200094B/xx unknown
- 2002-01-15 NO NO20020217A patent/NO20020217L/no not_active Application Discontinuation
- 2002-07-26 US US10/205,792 patent/US6716841B2/en not_active Expired - Lifetime
- 2002-09-27 HK HK02106604.3A patent/HK1045502B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2001005784A1 (fr) | 2001-01-25 |
NO20020217D0 (no) | 2002-01-15 |
CA2380727A1 (fr) | 2001-01-25 |
US6429205B1 (en) | 2002-08-06 |
ES2222257T3 (es) | 2005-02-01 |
CN1454211A (zh) | 2003-11-05 |
DE60011430T2 (de) | 2005-07-07 |
AU2481501A (en) | 2001-02-05 |
MXPA02000537A (es) | 2004-09-10 |
IL147317A0 (en) | 2002-08-14 |
HK1045502A1 (en) | 2002-11-29 |
DE60011430D1 (de) | 2004-07-15 |
US6716841B2 (en) | 2004-04-06 |
NO20020217L (no) | 2002-03-15 |
US20030096820A1 (en) | 2003-05-22 |
KR20030011268A (ko) | 2003-02-07 |
HK1045502B (zh) | 2004-12-10 |
EP1196412B1 (fr) | 2004-06-09 |
EP1196412A1 (fr) | 2002-04-17 |
PL357108A1 (en) | 2004-07-12 |
ATE268766T1 (de) | 2004-06-15 |
BR0013200A (pt) | 2002-05-07 |
JP2004507439A (ja) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL147317A0 (en) | NITROGEN CONTAINING HETEROBICYCLES AS FACTOR Xa INHIBITORS | |
WO2002000651A3 (fr) | Inhibiteurs du facteur xa | |
BR9908280A (pt) | Inibidores de enzimas de fosfolipase | |
IL144032A0 (en) | Serine protease inhibitors | |
GEP20074098B (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
DE69816280D1 (de) | Inhibitoren des impdh-enzyms | |
WO2000055124A3 (fr) | Composes et compositions utilises comme inhibiteurs de protease | |
UA74372C2 (uk) | Інгібітори серинових протеаз, фармацевтична композиція на їх основі | |
NO990855L (no) | Substituerte sykliske amin-metallprotease-inhibitorer | |
EP1862457A3 (fr) | Fluoropyrrolidines en tant qu'inhibiteurs de la peptidase dipeptidyle | |
IL222773B (en) | Biaryl compounds, pharmaceutical preparations containing them, use of such compounds for the manufacture of drugs and in vitro methods and devices using such compounds | |
WO2005099709A3 (fr) | Heterocycles bicycliques convenant comme inhibiteurs de la serine protease | |
DE60324183D1 (en) | Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) | |
NO983688L (no) | Serin-protease-inhibitorer | |
WO2002080853A3 (fr) | Inhibiteurs heterocycliques fusionnes du facteur xa | |
WO2001044172A8 (fr) | Salicylamides utiles en tant qu'inhibiteurs des serines proteases | |
MY138303A (en) | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade | |
WO2002020475A3 (fr) | Inhibiteurs de l'activite de la serine protease de matriptase, ou mtsp1 | |
IL124883A0 (en) | Amidino protease inhibitors and pharmaceutical compositions containing the same | |
WO2001070204A3 (fr) | Inhibiteurs a selectivite elevee de l'activateur de type urokinase du plasminogene | |
WO2002002519A3 (fr) | Inhibiteurs de la thrombine ou du facteur xa | |
WO2003015715A3 (fr) | Derives de tetrahydroquinoline utilises comme agents antithrombotiques | |
AU8184301A (en) | Inhibitors for the blood-clotting factor xa | |
AU3719100A (en) | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections | |
WO2002094197A3 (fr) | Inhibiteurs bicycliques du facteur xa |